Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 17;38(12):224.
doi: 10.1007/s11274-022-03410-5.

Thidiazuron, a phenyl-urea cytokinin, inhibits ergosterol synthesis and attenuates biofilm formation of Candida albicans

Pandurangan Harikrishnan  1   2   3 , Balamani Arayambath  4 , Vijay Karthik Jayaraman  5 , Kanimozhi Ekambaram  6 , Emad A Ahmed  7 , Palanisamy Senthilkumar  8 , Hairul-Islam Mohamed Ibrahim  1   7 , Arjunan Sundaresan  1 , Krishnaraj Thirugnanasambantham  9   10
Affiliations

Thidiazuron, a phenyl-urea cytokinin, inhibits ergosterol synthesis and attenuates biofilm formation of Candida albicans

Pandurangan Harikrishnan et al. World J Microbiol Biotechnol. .

Abstract

Candida albicans is a common human fungal pathogen that colonizes mucosa and develops biofilm in the oral cavity that causes oral candidiasis. It has been reported that cytochrome P450 enzyme (CYP51), a vital part of the ergosterol synthesis cascade, is associated with Candida infections and its biofilm formation. Thidiazuron, a phenyl-urea cytokinin, exhibits anti-senescence and elicitor activity against fungal infection in plants. However, how Thidiazuron impacts C. albicans biofilm formation is still uncertain. Here, we aimed to investigate the effects of a Thidiazuron against the growth and biofilm formation properties of C. albicans using in silico and in vitro experimental approaches. A preliminary molecular docking study revealed potential interaction between Thidiazuron and amino acid residues of CYP51. Further in vitro antifungal susceptibility test, scanning electron microscopy (SEM) and time kill analysis revealed the anti-fungal activity of Thidiazuron in both dose and time-dependent manner. Crystal violet staining, 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduction assay revealed 50% inhibition in C. albicans biofilm by Thidiazuron at concentrations 11 and 19 µM respectively. Acridine orange staining assay visually confirmed the biofilm inhibitory potential of Thidiazuron. The gene expression study showed that Thidiazuron treatment down regulated the expression of genes involved in ergosterol synthesis (ERG3, ERG11, ERG25), cell adhesion (ASL3, EAP1), and hyphae development (EFG1, HWP1, SAP5) in C. albicans. Wherease, the expression of negative transcription regulator of hyphae (NRG1) was upregulated (5.7-fold) by Thidiazuron treatment. Collectively, our data suggest that Thidiazuron is a robust antifungal compound and an outstanding biofilm inhibitor, which may promise further therapeutic development due to CYP51 binding and inhibition of ergosterol formation against C. albicans.

Keywords: Anti-fungal; Biofilm; CYP51; Candida albicans; Ergosterol; Thidiazuron.

PubMed Disclaimer

References

    1. Akpan A (2002) Oral candidiasis. Postgrad Med J 78:455–459. https://doi.org/10.1136/pmj.78.922.455 - DOI - PubMed - PMC
    1. Ali I, Khan FG, Suri KA et al (2010) In vitro antifungal activity of hydroxychavicol isolated from Piper betle L. Ann Clin Microbiol Antimicrob 9:7. https://doi.org/10.1186/1476-0711-9-7 - DOI - PubMed - PMC
    1. Bennis S, Chami F, Chami N et al (2004) Surface alteration of Saccharomyces cerevisiae induced by thymol and eugenol. Lett Appl Microbiol 38:454–458. https://doi.org/10.1111/j.1472-765X.2004.01511.x - DOI - PubMed
    1. Blankenship JR, Mitchell AP (2006) How to build a biofilm: a fungal perspective. Curr Opin Microbiol 9:588–594. https://doi.org/10.1016/j.mib.2006.10.003 - DOI - PubMed
    1. Bonilla Rodríguez Y, Moreno Maldonado V, Muñoz Hernández B, Palma Cortés G (2012) In vitro adhesion of Candida albicans in three different tissue conditioners used in prosthodontics. Rev Odontol Mex 16:40–45

LinkOut - more resources